Opening book details…
About this Biochemistry, Genetics and Molecular Biology article
Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events by Meißner, Tobias; Mark, Adam; Williams, Casey; Berdel, Wolfgang E.; Wiebe, Stephanie; Kerkhoff, Andrea; Wardelmann, Eva; Gaiser, Timo; Müller-Tidow, Carsten; Rosenstiel, Philip; Arnold, Norbert; Leyland-Jones, Brian; Franke, Andre; Stanulla, Martin; Forster, Michael is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Meißner, Tobias; Mark, Adam; Williams, Casey; Berdel, Wolfgang E.; Wiebe, Stephanie; Kerkhoff, Andrea; Wardelmann, Eva; Gaiser, Timo; Müller-Tidow, Carsten; Rosenstiel, Philip; Arnold, Norbert; Leyland-Jones, Brian; Franke, Andre; Stanulla, Martin; Forster, Michael
- Publisher
- Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory Press (ISSN 2373-2865)
- Published
- 2017
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)